<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02258230</url>
  </required_header>
  <id_info>
    <org_study_id>4859</org_study_id>
    <nct_id>NCT02258230</nct_id>
  </id_info>
  <brief_title>Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair</brief_title>
  <official_title>Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Olympus Corporation of the Americas</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Urogynecology Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Olympus Corporation of the Americas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare operative times and complications of sacral colpopexy and paravaginal repair between&#xD;
      two-dimensional and three-dimensional laparoscopic systems.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to compare operative times of laparoscopic sacral colpopexy&#xD;
      (LSC) for the treatment of symptomatic vaginal vault prolapse as well as paravaginal repair&#xD;
      (PVR) for symptomatic cystocele between two-dimensional and three-dimensional laparoscopic&#xD;
      systems. Additionally this study will evaluate postoperative complications from surgeries&#xD;
      performed using two-dimensional versus three-dimensional laparoscopic systems.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operative Times</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Operative times of laparoscopic sacral colpopexy and paravaginal repair procedures from the first part of dissection until closure of the peritoneum.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Intraoperative up to 6 weeks post procedure</time_frame>
    <description>Intraoperative complications will be recorded. Post operative complications will be reported for the first 6 weeks after the procedure.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">194</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Cystocele</condition>
  <arm_group>
    <arm_group_label>2D mode LSC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2D mode of the 3D Laparoscopic Video System for the Laprascopic Sacral Colpopexy (LSC) arm. Use of the 3D laparoscopic system can be switched to either 2D or 3D.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D mode LSC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3D mode of the 3D Laparoscopic Video System for the Laprascopic Sacral Colpopexy (LSC) arm. Use of the 3D laparoscopic system can be switched to either 2D or 3D.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D mode PVR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2D mode of the 3D Laparoscopic Video System for the Paravaginal Repair (PVR) arm. Use of the 3D laparoscopic system can be switched to either 2D or 3D.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D mode PVR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3D mode of the 3D Laparoscopic Video System for the Paravaginal Repair (PVR) arm. Use of the 3D laparoscopic system can be switched to either 2D or 3D.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D mode of the 3D Laparoscopic Video System</intervention_name>
    <description>Olympus 3DV-190 3D Visualization Unit. LTF-190-10-3D: ENDOEYE FLEX 3D Videoscope.</description>
    <arm_group_label>3D mode LSC</arm_group_label>
    <arm_group_label>3D mode PVR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2D mode of the 3D Laparoscopic Video System</intervention_name>
    <description>Olympus 3DV-190 3D Visualization Unit. LTF-190-10-3D: ENDOEYE FLEX 3D Videoscope.</description>
    <arm_group_label>2D mode LSC</arm_group_label>
    <arm_group_label>2D mode PVR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic vaginal vault prolapse (stage 2 or greater point C-1 pelvic organ prolapse&#xD;
             quantification [POP-Q] or grade 2 or greater Baden-Walker half way system) undergoing&#xD;
             laparoscopic sacral colpopexy&#xD;
&#xD;
        And/Or&#xD;
&#xD;
          -  Symptomatic cystocele (stage 2 or greater, point Aa or Ba &gt; -1 POP-Q or grade 2 or&#xD;
             greater Baden-Walker half way system) undergoing laparoscopic paravaginal repair&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 18 years&#xD;
&#xD;
          -  Inability to comprehend questionnaires&#xD;
&#xD;
          -  Inability to give informed consent or to return for review&#xD;
&#xD;
          -  Vaginal vault prolapse &lt; stage 2&#xD;
&#xD;
          -  Unable to undergo general anesthesia&#xD;
&#xD;
          -  More than 5 previous laparotomies&#xD;
&#xD;
          -  Prior sacral colpopexy or vaginal mesh prolapse procedure&#xD;
&#xD;
          -  Prior surgery involving the retropubic space&#xD;
&#xD;
          -  Vaginal length less than 6 cm&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert D Moore, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Urogynecology Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beverly Hills Sunset Surgery Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northside Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.miklosandmoore.com/</url>
    <description>International Urogynecology Associates' website</description>
  </link>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>October 2, 2014</study_first_submitted>
  <study_first_submitted_qc>October 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2014</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystocele</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

